Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 321

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 321
---
────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Table of Contents

Director Compensation

The following table sets forth a summary of the compensation we paid to our directors other than Dr. Weiguo Su and Mr. Cheng Chig Fung, Johnny during 2024.

                                                           Maximum Value of Non-   
                              Fees Earned or               Performance Based LTIP  
  Name of Director            Paid in Cash                 Awards Granted          
  TO Chi Keung, Simon         $31,817             (1)                              
  Dan ELDAR                   $81,339                                              
  Edith SHIH                  —                   (2)                              
  Ling YANG                   —                                                    
  Paul Rutherford CARTER      $117,000                                             
  Renu RHATIA                 $59,119                                              
  Chaohong HU                 $9,410                                               
  Graeme Allan JACK           $111,000                                             
  MOK Shu Kam, Tony           $115,857                                             

Notes:

  (1)      Such director ’ s fees were paid to Hutchison Whampoa (China) Limited, a wholly owned subsidiary of CK Hutchison. Director ’ s fees received from our subsidiaries during the period Mr. To serve...  

  (2)      Director ’ s fees received from our subsidiaries during the period Ms. Shih served as director that were paid to a subsidiary of CK Hutchison are not included.  

Equity Compensation Schemes and Other Benefit Plans

In April 2015, our shareholders adopted an option scheme (“2015 Option Scheme”), which was later approved by the shareholders of CK Hutchison, the ultimate parent of our then majority shareholder, in May 2016. The 2015 Option Scheme was subsequently amended in April 2020.

We also have a long-term incentive scheme which was adopted by our shareholders in April 2015 and will expire on April 24, 2025. We refer to this as our LTIP. In March 2025, our board of directors approved the adoption of another ten-year LTIP scheme to be effective from April 24, 2025.

The 2015 Option Scheme and LTIP each terminates on the tenth anniversary of their adoption. Each may also be terminated by its board of directors at any time. Any termination of a scheme is without prejudice to the awards outstanding at such time.

The following describes the material terms of our 2015 Option Scheme and LTIP (collectively,